Li Xiu-Mei, Luo Xue-Gang, He Jun-Fang, Wang Nan, Zhou Hao, Yang Pei-Long, Zhang Tong-Cun
Key Laboratory for Feed Biotechnology of The Ministry of Agriculture, National Engineering Research Center of Biological Feed, Feed Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, P.R. China.
Key Laboratory of Industrial Fermentation Microbiology of The Ministry of Education, Tianjin Key Laboratory of Industrial Microbiology, College of Biotechnology, Tianjin University of Science and Technology, Tianjin, Hebei 300457, P.R. China.
Oncol Lett. 2018 Mar;15(3):3944-3950. doi: 10.3892/ol.2018.7812. Epub 2018 Jan 16.
L. (Great St. Johnswort), which belongs to the Hypericaceae family, has been used for the treatment of hematemesis, metrorrhagia, rheumatism, swelling, stomach ache, abscesses, dysentery and irregular menstruation for >2,000 years in China. The aim of the present study was to clarify the anticancer activity compounds from L. and the underlying molecular mechanism. Anticancer activity of L. extract was evaluated using an MTT assay. To confirm the anticancer mechanism of activity compounds, Hoechst 33258, Annexin V-fluorescein isothiocyanate/propidium iodide, 2',7'-dichlorodihydrofluorescein diacetate, rhodamine 123 staining and caspase-3 activity analysis were performed. The results demonstrated that the anti-proliferative action of the mixture of kaempferol 3-O-β-(2″-acetyl) galactopyranoside (K) and quercetin (Q) (molar ratio, 1:1) was significantly increased compared with either of these two compounds separately, and the active fraction of the L. extract |(HALE). HALE, indicating that the anti-proliferative function of L. may be a synergic effect of K and Q. Furthermore, the inhibitory effect of KQ on the growth of HeLa cells was mediated by the induction of apoptosis. To the best of our knowledge, the present study is the first to identify that KQ exhibits significant anti-proliferation activity on HeLa cells via the apoptotic pathway, and is also the first to evaluate the anticancer potential of L. The results of the present study may provide a rational base for the use of L. in the clinic, and shed light on the development of novel anticancer drugs.
贯叶连翘(L.,大金丝桃)属于金丝桃科,在中国已有2000多年用于治疗吐血、崩漏、风湿、肿胀、胃痛、脓肿、痢疾和月经不调的历史。本研究的目的是阐明贯叶连翘中的抗癌活性化合物及其潜在的分子机制。采用MTT法评估贯叶连翘提取物的抗癌活性。为了证实活性化合物的抗癌机制,进行了Hoechst 33258、膜联蛋白V-异硫氰酸荧光素/碘化丙啶、2',7'-二氯二氢荧光素二乙酸酯、罗丹明123染色和半胱天冬酶-3活性分析。结果表明,山奈酚3-O-β-(2″-乙酰基)吡喃半乳糖苷(K)和槲皮素(Q)(摩尔比1:1)混合物的抗增殖作用与单独使用这两种化合物相比显著增强,且该混合物为贯叶连翘提取物的活性组分(HALE)。HALE表明贯叶连翘的抗增殖功能可能是K和Q的协同作用。此外,KQ对HeLa细胞生长的抑制作用是通过诱导细胞凋亡介导的。据我们所知,本研究首次确定KQ通过凋亡途径对HeLa细胞具有显著的抗增殖活性,也是首次评估贯叶连翘的抗癌潜力。本研究结果可为贯叶连翘在临床上的应用提供合理依据,并为新型抗癌药物的开发提供思路。